|
2020 Journal Article Nicotinamide for skin cancer chemoprevention: Effects of nicotinamide on melanoma: In vitro and in vivoMalesu, Rashi, Martin, Andrew J., Lyons, J. Guy, Scolyer, Richard A., Chen, Andrew C., McKenzie, Catriona A., Madore, Jason, Halliday, Gary M. and Damian, Diona L. (2020). Nicotinamide for skin cancer chemoprevention: Effects of nicotinamide on melanoma: In vitro and in vivo. Photochemical and Photobiological Sciences, 19 (2), 171-179. doi: 10.1039/c9pp00388f |
|
2020 Journal Article Lactoferrin infant feeding trial_Canada (LIFT_Canada): Protocol for a randomized trial of adding lactoferrin to feeds of very-low-birth-weight preterm infantsAsztalos, Elizabeth V., Barrington, Keith, Lodha, Abhay, Tarnow-Mordi, William and Martin, Andrew (2020). Lactoferrin infant feeding trial_Canada (LIFT_Canada): Protocol for a randomized trial of adding lactoferrin to feeds of very-low-birth-weight preterm infants. BMC Pediatrics, 20 (1) 40, 1-8. doi: 10.1186/s12887-020-1938-0 |
|
2019 Journal Article Physical Activity for Symptom Management in Women With Metastatic Breast Cancer: A Randomized Feasibility Trial on Physical Activity and Breast MetastasesYee, Jasmine, Davis, Glen M., Hackett, Daniel, Beith, Jane M., Wilcken, Nicholas, Currow, David, Emery, Jon, Phillips, Jane, Martin, Andrew, Hui, Rina, Harrison, Michelle, Segelov, Eva and Kilbreath, Sharon L. (2019). Physical Activity for Symptom Management in Women With Metastatic Breast Cancer: A Randomized Feasibility Trial on Physical Activity and Breast Metastases. Journal of Pain and Symptom Management, 58 (6), 929-939. doi: 10.1016/j.jpainsymman.2019.07.022 |
|
2019 Journal Article Should Genital Hiatus/Perineal Body Be Measured at Rest or on Valsalva?Ow, Lin Li, Subramaniam, Nishamini, Kamisan Atan, Ixora, Friedman, Talia, Martin, Andrew and Dietz, Hans Peter (2019). Should Genital Hiatus/Perineal Body Be Measured at Rest or on Valsalva?. Female Pelvic Medicine and Reconstructive Surgery, 25 (6), 415-418. doi: 10.1097/SPV.0000000000000608 |
|
2019 Journal Article TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)Hofman, Michael S., Emmett, Louise, Violet, John, Y. Zhang, Alison, Lawrence, Nicola J., Stockler, Martin, Francis, Roslyn J., Iravani, Amir, Williams, Scott, Azad, Arun, Martin, Andrew, McJannett, Margaret and Davis, Ian D. (2019). TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603). BJU International, 124 (S1), 5-13. doi: 10.1111/bju.14876 |
|
2019 Journal Article Accuracy and Prognostic Significance of Oncologists’ Estimates and Scenarios for Survival Time in Advanced Gastric CancerVasista, Anuradha, Stockler, Martin, Martin, Andrew, Pavlakis, Nick, Sjoquist, Katrin, Goldstein, David, Gill, Sanjeev, Jain, Vikram, Liu, Geoffrey, Kannourakis, George, Kim, Yeul Hong, Nott, Louise, Snow, Stephanie, Burge, Matthew, Harris, Dean, Jonker, Derek, Chua, Yu Jo, Epstein, Richard, Bonaventura, Antony and Kiely, Belinda (2019). Accuracy and Prognostic Significance of Oncologists’ Estimates and Scenarios for Survival Time in Advanced Gastric Cancer. Oncologist, 24 (11), e1102-e1107. doi: 10.1634/theoncologist.2018-0613 |
|
2019 Journal Article Postoperative pain and comfort scores: Do they correlate?Miu, Michelle W., Martin, Andrew and Cyna, Allan M. (2019). Postoperative pain and comfort scores: Do they correlate?. Anaesthesia and Intensive Care, 47 (5), 435-441. doi: 10.1177/0310057X19861985 |
|
2019 Journal Article Assumptions, damn assumptions and statisticsSimes, R. J. and Martin, A. J. (2019). Assumptions, damn assumptions and statistics. Annals of Oncology, 30 (9), 1415-1416. doi: 10.1093/annonc/mdz209 |
|
2019 Journal Article Enzalutamide with standard first-line therapy in metastatic prostate cancerDavis, Ian D., Martin, Andrew J., Stockler, Martin R., Begbie, Stephen, Chi, Kim N., Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E., Horvath, Lisa G., Joshua, Anthony M., Lawrence, Nicola J., Marx, Gavin, McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A., Parnis, Francis, Parulekar, Wendy, Pook, David W., Neil Reaume, M., Sandhu, Shahneen K., Tan, Alvin, Hsiang Tan, T., Thomson, Alastair, Tu, Emily, Vera-Badillo, Francisco, Williams, Scott G., Yip, Sonia ... for the ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (2019). Enzalutamide with standard first-line therapy in metastatic prostate cancer. New England Journal of Medicine, 381 (2), 121-131. doi: 10.1056/NEJMoa1903835 |
|
2019 Journal Article The Chest Australia Trial: A randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancerEmery, Jon D., Murray, Sonya R., Walter, Fiona M., Martin, Andrew, Goodall, Stephen, Mazza, Danielle, Habgood, Emily, Kutzer, Yvonne, Barnes, David John and Murchie, Peter (2019). The Chest Australia Trial: A randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer. Thorax, 74 (4), 362-370. doi: 10.1136/thoraxjnl-2018-212506 |
|
2019 Journal Article Oncologists’ perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancerMoth, Erin B., Kiely, Belinda E., Stefanic, Natalie, Naganathan, Vasikaran, Martin, Andrew, Grimison, Peter, Stockler, Martin R., Beale, Philip and Blinman, Prunella (2019). Oncologists’ perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancer. Journal of Geriatric Oncology, 10 (2), 210-215. doi: 10.1016/j.jgo.2018.11.004 |
|
2019 Journal Article Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists’ estimates of toxicity based on clinical judgementMoth, Erin B., Kiely, Belinda E., Stefanic, Natalie, Naganathan, Vasikaran, Martin, Andrew, Grimison, Peter, Stockler, Martin R., Beale, Philip and Blinman, Prunella (2019). Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists’ estimates of toxicity based on clinical judgement. Journal of Geriatric Oncology, 10 (2), 202-209. doi: 10.1016/j.jgo.2018.08.010 |
|
2019 Journal Article Neurocognitive function and quality of life outcomes in the ONTRAC study for skin cancer chemoprevention by nicotinamideMartin, Andrew J., Dhillon, Haryana M., Vardy, Janette L., Dalziell, Robyn A., Choy, Bonita, Fernández-Peñas, Pablo, Dixon, Ann, Renton, Corrinne, St. George, Gayathri, Chinniah, Niranthari, Halliday, Gary M., Damian, Diona L. and Chen, Andrew C. (2019). Neurocognitive function and quality of life outcomes in the ONTRAC study for skin cancer chemoprevention by nicotinamide. Geriatrics, 4 (1) 31, 1-6. doi: 10.3390/geriatrics4010031 |
|
2019 Journal Article The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysisLee, Kirsty Wai Chung, Lord, Sally, Finn, Richard S., Lim, Elgene, Martin, Andrew, Loi, Sherene, Lynch, Jodi, Friedlander, Michael and Lee, Chee Khoon (2019). The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis. Breast Cancer Research and Treatment, 174 (1), 271-278. doi: 10.1007/s10549-018-5054-x |
|
2019 Journal Article A Reduction in Inflammatory Macrophages May Contribute to Skin Cancer Chemoprevention by NicotinamideMinocha, Rashi, Martin, Andrew J., Chen, Andrew C., Scolyer, Richard A., Lyons, J. Guy, McKenzie, Catriona A., Madore, Jason, Halliday, Gary M. and Damian, Diona L. (2019). A Reduction in Inflammatory Macrophages May Contribute to Skin Cancer Chemoprevention by Nicotinamide. Journal of Investigative Dermatology, 139 (2), 467-469. doi: 10.1016/j.jid.2018.08.018 |
|
2019 Journal Article Treatments used for obsessive–compulsive disorder—An international perspectiveBrakoulias, Vlasios, Starcevic, Vladan, Albert, Umberto, Arumugham, Shyam Sundar, Bailey, Brenda E., Belloch, Amparo, Borda, Tania, Dell'Osso, Liliana, Elias, Jason A., Falkenstein, Martha J., Ferrao, Ygor A., Fontenelle, Leonardo F., Jelinek, Lena, Kalogeraki, Leto, Kay, Brian, Laurito, Luana D., Lochner, Christine, Maina, Giuseppe, Marazziti, Donatella, Martin, Andrew, Matsunaga, Hisato, Miguel, Euripedes C., Morgado, Pedro, Mourikis, Irakis, Pasquini, Massimo, Perez Rivera, Rodrigo, Potluri, Sriramya, Reddy, Janardhan Y.C., Riemann, Brian C. ... Fineberg, Naomi A. (2019). Treatments used for obsessive–compulsive disorder—An international perspective. Human Psychopharmacology, 34 (1) e2686, 1-10. doi: 10.1002/hup.2686 |
|
2018 Journal Article Protocol for the Lactoferrin Infant Feeding Trial (LIFT): A randomised trial of adding lactoferrin to the feeds of very-low birthweight babies prior to hospital dischargeMartin, Andrew, Ghadge, Alpana, Manzoni, Paolo, Lui, Kei, Brown, Rebecca, Tarnow-Mordi, William, Lu, Kei, Simes, John, Hague, Wendy, Osborn, David, Deshpande, Girish, Kochar, Anu, Lewis, Tony, Watkins, Andrew, Pritchard, Margo, Schofield, Deborah, Mohamed, Abdel Latif, Soll, Roger, Darlow, Brian, Isaacs, David, Wilkinson, Dominic, Wood, Alicia, McKenzie, Anne, Despande, Girish, Verry, Hannah, Wright, Ian, Askie, Lisa, Cruz, Melinda, Berry, Nina ... Espinoza, David (2018). Protocol for the Lactoferrin Infant Feeding Trial (LIFT): A randomised trial of adding lactoferrin to the feeds of very-low birthweight babies prior to hospital discharge. BMJ Open, 8 (10) e023044. doi: 10.1136/bmjopen-2018-023044 |
|
2018 Journal Article Effect Sizes Hypothesized and Observed in Contemporary Phase III Trials of Targeted and Immunological Therapies for Advanced CancerLawrence, Nicola Jane, Roncolato, Felicia, Martin, Andrew, Simes, Robert John and Stockler, Martin R. (2018). Effect Sizes Hypothesized and Observed in Contemporary Phase III Trials of Targeted and Immunological Therapies for Advanced Cancer. JNCI Cancer Spectrum, 2 (4) pky037, 1-7. doi: 10.1093/JNCICS/PKY037 |
|
2018 Journal Article Protocol for the P3BEP trial (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumoursLawrence, Nicola J., Chan, Howard, Toner, Guy, Stockler, Martin R., Martin, Andrew, Yip, Sonia, Wong, Nicole, Yeung, Annie, Mazhar, Danish, Pashankar, Farzana, Frazier, Lindsay, McDermott, Ray, Walker, Roderick, Tan, Hsiang, Davis, Ian D. and Grimison, Peter (2018). Protocol for the P3BEP trial (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours. BMC Cancer, 18 (1) 854, 1-6. doi: 10.1186/s12885-018-4745-3 |
|
2018 Journal Article The LEAD study protocol: A mixed-method cohort study evaluating the lung cancer diagnostic and pre-treatment pathways of patients from Culturally and Linguistically Diverse (CALD) backgrounds compared to patients from Anglo-Australian backgroundsMazza, Danielle, Lin, Xiaoping, Walter, Fiona M., Young, Jane M., Barnes, David J., Mitchell, Paul, Brijnath, Bianca, Martin, Andrew and Emery, Jon D. (2018). The LEAD study protocol: A mixed-method cohort study evaluating the lung cancer diagnostic and pre-treatment pathways of patients from Culturally and Linguistically Diverse (CALD) backgrounds compared to patients from Anglo-Australian backgrounds. BMC Cancer, 18 (1) 754, 1-8. doi: 10.1186/s12885-018-4671-4 |
